Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Range anxiety has haunted EV buyers since Tesla’s first Roadster, turning every road trip into a charging station treasure hunt. Factorial Energy and Karma Automotive just announced the cure: ...

Solid-state EV batteries, deemed the “holy grail” of battery tech, are moving from the lab to reality, even in the US. Factorial launches solid-state battery program in the US Factorial Energy has ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Posco Future M, the battery materials subsidiary of South Korea’s steel and chemicals firm Posco Group, announced it has made a strategic investment in Factorial Inc, a US-based developer of materials ...

Posco Future M has made a direct investment in U.S.-based solid-state battery company Factorial Energy as part of its growth strategy focused on the next-generation battery market, the company said ...